CTNNB1 and pilomatrixoma: Activated mutations in CTNNB1 leading to upregulation of beta-catenin have been observed in pilomatricomas [35, 36] and pilomatrical carcinomas [35], especially mutations in exon 3 of the gene which have been observed in approximately 60-75% of pilomatricomas [36].